Finally, CDDP-treated tumor cells have shown an enhanced activation of migratory proteins such as Rac, Rho A, AKT, and FAK and an over-expression of migration-associated integrins such as αv, α4, and β1/β5 [50]. The gene discussed is AKT1; the disease is neoplasm.